Ab­b­Vie sues five gener­ic com­pa­nies over po­ten­tial Rin­voq com­peti­tors

Ab­b­Vie spent the last decade pro­tect­ing its top-sell­ing Hu­mi­ra (adal­i­mum­ab) fran­chise from biosim­i­lar com­pe­ti­tion, and now the Chica­go-based com­pa­ny is su­ing five gener­ic drug com­pa­nies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER